![]() Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. | ![]() Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | |||
Founding Date | Founding Date 2013 | Founding Date 2011 | Founding Date N/A | Founding Date 2009 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US | Locations Cambridge, US HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more |
Employees | Employees 1091% decrease | Employees 378% decrease | Employees 29723% increase | Employees 3,9671% decrease |
Financial | ||||
Revenue (est.) | Revenue (est.) $111.9m (FY, 2017) | Revenue (est.) N/A | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($437.1m) (FY, 2017) | Net income N/A | Net income (€196.4m) (FY, 2025) | Net income N/A |
Operating ⚠ | ||||
Trademarks (US) | Trademarks (US) N/A | Trademarks (US) 3 (Jul, 2021) | Trademarks (US) N/A | Trademarks (US) 19 (Jan, 2024) |
Funding | ||||
Total funding raised | Total funding raised $ 310m | Total funding raised $ 200m | Total funding raised $ 267.3m | Total funding raised $ 85.3m |
H3 Biomedicine is a biopharmaceutical company that specializes in cancer genomics.
View company
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company
Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.
View company